Rev Esp Quimioter 2022;35(Suppl.3):89-93

Models for bacteraemia risk prediction. Clinical implications

CARLOTA CLEMENTE-CALLEJO, AGUSTÍN JULIÁN-JIMÉNEZ, FRANCISCO JAVIER CANDEL GONZÁLEZ, JUAN GONZÁLEZ DEL CASTILLO

Published: 24 October 2022

http://www.doi.org/10.37201/req/s03.19.2022

Bacteraemia has important consequences for the patient, as it is associated with worse clinical outcomes. On the other hand, unnecessarily obtaining samples for blood cultures increases costs and the workload in the microbiology laboratory. Its diagnosis implies a time delay, but decisions about start antibiotic treatment, discharge, or admits the patient must be taken during the first attention and, therefore, before known the blood cultures results. This manuscript reviews the different strategies based on clinical scores and biomarkers that are useful for predicting bacteraemia and improving initial decision-making.

Rev Esp Quimioter 2022; 35(Suppl.3):89-93 [Full-text PDF]